Skip to Content

Link Reservations Inc LRSV

Morningstar Rating
$0.00 0.00 (33.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LRSV is trading at a 510% premium.
Price
$0.00
Fair Value
$9.24
Uncertainty
Extreme
1-Star Price
$8.20
5-Star Price
$1.95
Economic Moat
Jmq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LRSV is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$1.69 Mil
Volume/Avg
600,000 / 115,724

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Link Reservations Inc, through its subsidiary, is focused on providing and developing cannabidiol oil (CBD) and Hemp-based products for animals - dogs, cats, and horses. Its line of products addresses allergy and immune system support, hip and joint mobility, anxiety and comfort, and everyday health and wellness for animals.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
LRSV
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LRSV
Quick Ratio
0.41
Current Ratio
0.61
Interest Coverage
−3.37
Quick Ratio
LRSV

Profitability

Metric
LRSV
Return on Assets (Normalized)
−204.89%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
GnjvdzxyrCwkgb$81.5 Bil
Merck KGaA ADR
MKKGY
HhxjsbffmNlfykwx$70.9 Bil
Haleon PLC ADR
HLN
BzxfrbzYwhmg$40.1 Bil
Viatris Inc
VTRS
VnfplrxcJpjcs$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
XzkwpzqsWylwq$13.2 Bil
Catalent Inc
CTLT
CfrqxqkyLqttxh$10.5 Bil
Perrigo Co PLC
PRGO
CglzlwkyhYsmz$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
ClgpzhfGfftqbg$3.5 Bil
Curaleaf Holdings Inc
CURLF
PtwqdhgzQft$3.1 Bil
Green Thumb Industries Inc
GTBIF
XzhnvdxtpvVsq$2.6 Bil

Sponsor Center